Skip to content

13F-HR filed by Column Group LLC

Column Group LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 7 holding rows worth $160,538,969.

Accession
0000950123-24-005685
Filed
2024-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 7 entries on the cover page, a total value of $160,538,969 stated on the cover page (in dollars after the unit check, H1), rows summing to $160,538,969 with VALUE read as dollars as filed, 13F file number 028-20797. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TENAYA THERAPEUTICS INC87990A106COM9,400,290$49,163,517dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM3,540,777$48,685,684dollars as filed
NGM BIOPHARMACEUTICALS INC62921N105COM18,136,735$28,837,409dollars as filed
RAPT THERAPEUTICS INC75382E109COM2,680,621$24,071,977dollars as filed
Surrozen, Inc.86889P109COM616,540$9,685,843dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK17,169$93,056dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock46$1,483dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-005685this filing2024-05-15acceptance time not in the bulk data set